Castlight Health (CSLT) Misses Q4 EPS by 2c, Revenues Beat; Offers FY20 EPS Guidance Below Consensus, FY20 Revenue Mid-Point Outlook Below Consensus

Go back to Castlight Health (CSLT) Misses Q4 EPS by 2c, Revenues Beat; Offers FY20 EPS Guidance Below Consensus, FY20 Revenue Mid-Point Outlook Below Consensus

Castlight Health Inc. (CSLT) PT Lowered to $2 at Cantor Fitzgerald Following Earnings

February 26, 2020 6:40 AM EST

Cantor Fitzgerald analyst Steven Halper lowered the price target on Castlight Health Inc. (NYSE: CSLT) to $2.00 (from $3.00) while maintaining a Neutral rating.

The analyst comments "As expected, ARR benefited from the previously-announced expansion of its Anthem relationship (ANTM - Overweight). Anthem now... More